Year: 1997
Type: article
Abstract: Article AbstractLetter to the Editor Sir: The trend of using serotonin selective reuptake inhibitors(SSRIs) as first-line therapy for depression has broughtsafe, effective, and well-tolerated therapy to countless patients.However, many men and women taking these drugs (fluoxetine,fluvoxamine, paroxetine, and sertraline) experience orgasmicdysfunction. Attempts to help these unfortunate patients withcyproheptadine, amantadine, yohimbine, and methylphenidatehave had mixed success.
Author: Ronald D. Reynolds
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2000559416